1H-Androstano3,2-cpyrazol-17-ol, 17-methyl-, (5.alpha.,17.beta.)-
- CAS No.
- 302-96-5
- Chemical Name:
- 1H-Androstano3,2-cpyrazol-17-ol, 17-methyl-, (5.alpha.,17.beta.)-
- Synonyms
- 1H-Androstano3,2-cpyrazol-17-ol, 17-methyl-, (5.alpha.,17.beta.)-;(1S,2S,10S,13R,14S,17S,18S)-2,17,18-trimethyl-6,7-diazapentacyclo[11.7.0.02,1?.0?,?.01?,1?]icosa-4,7-dien-17-ol
- CBNumber:
- CB51210061
- Molecular Formula:
- C21H32N2O
- Molecular Weight:
- 328.49158
- MDL Number:
- MOL File:
- 302-96-5.mol
| Boiling point | 466.22°C (rough estimate) |
|---|---|
| Density | 1.0279 (rough estimate) |
| refractive index | 1.6500 (estimate) |
| FDA UNII | 4R1VB9P8V3 |
1H-Androstano3,2-cpyrazol-17-ol, 17-methyl-, (5.alpha.,17.beta.)- Chemical Properties,Uses,Production
Definition
ChEBI: Stanozolol is an organic heteropentacyclic compound resulting from the formal condensation of the 3-keto-aldehyde moiety of oxymetholone with hydrazine. Like oxymetholone, it is a synthetic anabolic steroid. It has both anabolic and androgenic properties, and has been used to treat hereditary angioedema and various vascular disorders. It has also been widely abused by professional athletes. It has a role as an androgen and an anabolic agent. It is a 17beta-hydroxy steroid, a tertiary alcohol, an anabolic androgenic steroid and an organic heteropentacyclic compound. It is functionally related to an oxymetholone.
Safety Profile
Human systemic effects byingestion: jaundice. An experimental teratogen. Otherexperimental reproductive effects. When heated todecomposition it emits toxic fumes of NOx.